Intellipharmaceutics International Inc. (IPCI)

[Samsa]

Tilator, actually a deal for Regabatin with that hypothetical up front payment right now would be huge. Think about the ramifications.

we currently had 3.5 million cash on hand. a 10 million payment would give us 13.5 million. Thats just about enough for 1 full year of operating costs.

give us a year from now and what is in store? Rexista should be approved by this time next year assuming they file in September. They can partner that with say another 5 million up front. that now gets us through fiscal year 2019 without further dilution. by the year end 2019, Rexista should be on market. this also gives them time to get the generics figured out.

so no need to further dilute and cash on hand until the pipeline can deliver. a deal right now for Regabatin in the 10 million range would be a turning point.